Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries : an analysis of 123 nationally representative surveys
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved..
BACKGROUND: Antihypertensive medicines are effective in reducing adverse cardiovascular events. Our aim was to compare hypertension awareness, treatment, and control, and how they have changed over time, in high-income countries.
METHODS: We used data from people aged 40-79 years who participated in 123 national health examination surveys from 1976 to 2017 in 12 high-income countries: Australia, Canada, Finland, Germany, Ireland, Italy, Japan, New Zealand, South Korea, Spain, the UK, and the USA. We calculated the proportion of participants with hypertension, which was defined as systolic blood pressure of 140 mm Hg or more, or diastolic blood pressure of 90 mm Hg or more, or being on pharmacological treatment for hypertension, who were aware of their condition, who were treated, and whose hypertension was controlled (ie, lower than 140/90 mm Hg).
FINDINGS: Data from 526 336 participants were used in these analyses. In their most recent surveys, Canada, South Korea, Australia, and the UK had the lowest prevalence of hypertension, and Finland the highest. In the 1980s and early 1990s, treatment rates were at most 40% and control rates were less than 25% in most countries and age and sex groups. Over the time period assessed, hypertension awareness and treatment increased and control rate improved in all 12 countries, with South Korea and Germany experiencing the largest improvements. Most of the observed increase occurred in the 1990s and early-mid 2000s, having plateaued since in most countries. In their most recent surveys, Canada, Germany, South Korea, and the USA had the highest rates of awareness, treatment, and control, whereas Finland, Ireland, Japan, and Spain had the lowest. Even in the best performing countries, treatment coverage was at most 80% and control rates were less than 70%.
INTERPRETATION: Hypertension awareness, treatment, and control have improved substantially in high-income countries since the 1980s and 1990s. However, control rates have plateaued in the past decade, at levels lower than those in high-quality hypertension programmes. There is substantial variation across countries in the rates of hypertension awareness, treatment, and control.
FUNDING: Wellcome Trust and WHO.
| Errataetall: |
CommentIn: Lancet. 2019 Aug 24;394(10199):613-615. - PMID 31327567 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:394 |
|---|---|
| Enthalten in: |
Lancet (London, England) - 394(2019), 10199 vom: 24. Aug., Seite 639-651 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
NCD Risk Factor Collaboration (NCD-RisC) [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antihypertensive Agents |
|---|
| Anmerkungen: |
Date Completed 14.10.2019 Date Revised 09.03.2020 published: Print-Electronic CommentIn: Lancet. 2019 Aug 24;394(10199):613-615. - PMID 31327567 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S0140-6736(19)31145-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM299399796 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM299399796 | ||
| 003 | DE-627 | ||
| 005 | 20231225100240.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(19)31145-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0997.xml |
| 035 | |a (DE-627)NLM299399796 | ||
| 035 | |a (NLM)31327564 | ||
| 035 | |a (PII)S0140-6736(19)31145-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a NCD Risk Factor Collaboration (NCD-RisC) |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries |b an analysis of 123 nationally representative surveys |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.10.2019 | ||
| 500 | |a Date Revised 09.03.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Lancet. 2019 Aug 24;394(10199):613-615. - PMID 31327567 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a BACKGROUND: Antihypertensive medicines are effective in reducing adverse cardiovascular events. Our aim was to compare hypertension awareness, treatment, and control, and how they have changed over time, in high-income countries | ||
| 520 | |a METHODS: We used data from people aged 40-79 years who participated in 123 national health examination surveys from 1976 to 2017 in 12 high-income countries: Australia, Canada, Finland, Germany, Ireland, Italy, Japan, New Zealand, South Korea, Spain, the UK, and the USA. We calculated the proportion of participants with hypertension, which was defined as systolic blood pressure of 140 mm Hg or more, or diastolic blood pressure of 90 mm Hg or more, or being on pharmacological treatment for hypertension, who were aware of their condition, who were treated, and whose hypertension was controlled (ie, lower than 140/90 mm Hg) | ||
| 520 | |a FINDINGS: Data from 526 336 participants were used in these analyses. In their most recent surveys, Canada, South Korea, Australia, and the UK had the lowest prevalence of hypertension, and Finland the highest. In the 1980s and early 1990s, treatment rates were at most 40% and control rates were less than 25% in most countries and age and sex groups. Over the time period assessed, hypertension awareness and treatment increased and control rate improved in all 12 countries, with South Korea and Germany experiencing the largest improvements. Most of the observed increase occurred in the 1990s and early-mid 2000s, having plateaued since in most countries. In their most recent surveys, Canada, Germany, South Korea, and the USA had the highest rates of awareness, treatment, and control, whereas Finland, Ireland, Japan, and Spain had the lowest. Even in the best performing countries, treatment coverage was at most 80% and control rates were less than 70% | ||
| 520 | |a INTERPRETATION: Hypertension awareness, treatment, and control have improved substantially in high-income countries since the 1980s and 1990s. However, control rates have plateaued in the past decade, at levels lower than those in high-quality hypertension programmes. There is substantial variation across countries in the rates of hypertension awareness, treatment, and control | ||
| 520 | |a FUNDING: Wellcome Trust and WHO | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Antihypertensive Agents |2 NLM | |
| 700 | 1 | |a Zhou, Bin |e investigator |4 oth | |
| 700 | 1 | |a Danaei, Goodarz |e investigator |4 oth | |
| 700 | 1 | |a Stevens, Gretchen A |e investigator |4 oth | |
| 700 | 1 | |a Bixby, Honor |e investigator |4 oth | |
| 700 | 1 | |a Taddei, Cristina |e investigator |4 oth | |
| 700 | 1 | |a Carrillo-Larco, Rodrigo M |e investigator |4 oth | |
| 700 | 1 | |a Solomon, Bethlehem |e investigator |4 oth | |
| 700 | 1 | |a Riley, Leanne M |e investigator |4 oth | |
| 700 | 1 | |a Di Cesare, Mariachiara |e investigator |4 oth | |
| 700 | 1 | |a Iurilli, Maria Laura Caminia |e investigator |4 oth | |
| 700 | 1 | |a Rodriguez-Martinez, Andrea |e investigator |4 oth | |
| 700 | 1 | |a Zhu, Aubrianna |e investigator |4 oth | |
| 700 | 1 | |a Hajifathalian, Kaveh |e investigator |4 oth | |
| 700 | 1 | |a Amuzu, Antoinette |e investigator |4 oth | |
| 700 | 1 | |a Banegas, José R |e investigator |4 oth | |
| 700 | 1 | |a Bennett, James E |e investigator |4 oth | |
| 700 | 1 | |a Cameron, Christine |e investigator |4 oth | |
| 700 | 1 | |a Cho, Yumi |e investigator |4 oth | |
| 700 | 1 | |a Clarke, Janine |e investigator |4 oth | |
| 700 | 1 | |a Craig, Cora L |e investigator |4 oth | |
| 700 | 1 | |a Cruz, Juan J |e investigator |4 oth | |
| 700 | 1 | |a Gates, Louise |e investigator |4 oth | |
| 700 | 1 | |a Giampaoli, Simona |e investigator |4 oth | |
| 700 | 1 | |a Gregg, Edward W |e investigator |4 oth | |
| 700 | 1 | |a Hardy, Rebecca |e investigator |4 oth | |
| 700 | 1 | |a Hayes, Alison J |e investigator |4 oth | |
| 700 | 1 | |a Ikeda, Nayu |e investigator |4 oth | |
| 700 | 1 | |a Jackson, Rod T |e investigator |4 oth | |
| 700 | 1 | |a Jennings, Garry |e investigator |4 oth | |
| 700 | 1 | |a Joffres, Michel |e investigator |4 oth | |
| 700 | 1 | |a Khang, Young-Ho |e investigator |4 oth | |
| 700 | 1 | |a Koskinen, Seppo |e investigator |4 oth | |
| 700 | 1 | |a Kuh, Diana |e investigator |4 oth | |
| 700 | 1 | |a Kujala, Urho M |e investigator |4 oth | |
| 700 | 1 | |a Laatikainen, Tiina |e investigator |4 oth | |
| 700 | 1 | |a Lehtimäki, Terho |e investigator |4 oth | |
| 700 | 1 | |a Lopez-Garcia, Esther |e investigator |4 oth | |
| 700 | 1 | |a Lundqvist, Annamari |e investigator |4 oth | |
| 700 | 1 | |a Maggi, Stefania |e investigator |4 oth | |
| 700 | 1 | |a Magliano, Dianna J |e investigator |4 oth | |
| 700 | 1 | |a Mann, Jim I |e investigator |4 oth | |
| 700 | 1 | |a McLean, Rachael M |e investigator |4 oth | |
| 700 | 1 | |a McLean, Scott B |e investigator |4 oth | |
| 700 | 1 | |a Miller, Jody C |e investigator |4 oth | |
| 700 | 1 | |a Morgan, Karen |e investigator |4 oth | |
| 700 | 1 | |a Neuhauser, Hannelore K |e investigator |4 oth | |
| 700 | 1 | |a Niiranen, Teemu J |e investigator |4 oth | |
| 700 | 1 | |a Noale, Marianna |e investigator |4 oth | |
| 700 | 1 | |a Oh, Kyungwon |e investigator |4 oth | |
| 700 | 1 | |a Palmieri, Luigi |e investigator |4 oth | |
| 700 | 1 | |a Panza, Francesco |e investigator |4 oth | |
| 700 | 1 | |a Parnell, Winsome R |e investigator |4 oth | |
| 700 | 1 | |a Peltonen, Markku |e investigator |4 oth | |
| 700 | 1 | |a Raitakari, Olli |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez-Artalejo, Fernando |e investigator |4 oth | |
| 700 | 1 | |a Roy, Joel Gr |e investigator |4 oth | |
| 700 | 1 | |a Salomaa, Veikko |e investigator |4 oth | |
| 700 | 1 | |a Sarganas, Giselle |e investigator |4 oth | |
| 700 | 1 | |a Servais, Jennifer |e investigator |4 oth | |
| 700 | 1 | |a Shaw, Jonathan E |e investigator |4 oth | |
| 700 | 1 | |a Shibuya, Kenji |e investigator |4 oth | |
| 700 | 1 | |a Solfrizzi, Vincenzo |e investigator |4 oth | |
| 700 | 1 | |a Stavreski, Bill |e investigator |4 oth | |
| 700 | 1 | |a Tan, Eng Joo |e investigator |4 oth | |
| 700 | 1 | |a Turley, Maria L |e investigator |4 oth | |
| 700 | 1 | |a Vanuzzo, Diego |e investigator |4 oth | |
| 700 | 1 | |a Viikari-Juntura, Eira |e investigator |4 oth | |
| 700 | 1 | |a Weerasekera, Deepa |e investigator |4 oth | |
| 700 | 1 | |a Ezzati, Majid |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 394(2019), 10199 vom: 24. Aug., Seite 639-651 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
| 773 | 1 | 8 | |g volume:394 |g year:2019 |g number:10199 |g day:24 |g month:08 |g pages:639-651 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0140-6736(19)31145-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 394 |j 2019 |e 10199 |b 24 |c 08 |h 639-651 | ||